SMLR · As filed with the SEC

Semler Scientific income statement, by fiscal year

The statement as Semler Scientific presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Statements of Income · USD, except per-share amounts

USD, except per-share amountsFY2024
Year ended Dec 31, 2024
FY2023
Year ended Dec 31, 2023
FY2022
Year ended Dec 31, 2022
FY2021
Year ended Dec 31, 2021
Revenues56,294,000——53,027,000
Operating expenses:
Cost of revenues4,759,0006,984,0004,252,0006,122,000
Engineering and product development—5,773,0004,809,0003,780,000
Engineering and product development4,792,000———
Sales and marketing13,078,00018,147,00017,685,00014,445,000
General and administrative12,732,00014,290,00012,737,0009,235,000
Strategic streamlining—734,000——
Total operating expenses35,361,00045,928,00039,483,00033,582,000
Income from operations20,933,00022,256,00017,203,00019,445,000
Interest income——494,00010,000
Interest and dividend income, net1,877,0002,471,000——
Impairment of investments—(337,000)——
Change in fair value of notes held for investment128,000(307,000)——
Change in fair value of digital assets24,933,000———
Other income13,00017,0005,000—
Other income, net26,951,0001,844,000489,00010,000
Pre-tax income47,884,00024,100,00017,692,00019,455,000
Income tax provision6,985,0003,517,0003,367,0002,233,000
Net income40,899,00020,583,00014,325,00017,222,000
Net income per share, basic5.663.062.132.56
Weighted average number of shares used in computing basic net income per share7,228,9616,732,8066,726,6876,731,693
Net income per share, diluted5.132.631.792.12
Weighted average number of shares used in computing diluted net income per share7,980,1187,819,1597,999,7508,138,608
Revenues—68,184,00056,686,000—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.